Professor Robin Ferner MSc MD FRCP FBPharmacolS FBToxicolS

Professor Robin Ferner

Institute of Clinical Sciences
Honorary Professor of Clinical Pharmacology

Contact details

Address
City Hospital
Birmingham
B18 7QH

Robin Ferner is interested in medication errors and adverse drug reactions, and how to prevent them. In addition to over 120 original papers and over 85 reviews, he has written commentaries for the LancetBMJ, and British Journal of Clinical Pharmacology on these topics.

ORCID ID:

Qualifications


  • 1988 MD (‘Beta-Cell Responses to Glucose in Man’)
  • 1980 MRCP (UK)
  • 1978 MB BS
  • 1975 MSc
  • 1971 BSc

Biography

Robin Ferner retired from the NHS in 2017. He is an Honorary Consultant Physician and Clinical Pharmacologist at City Hospital Birmingham, Director Emeritus of the West Midlands Centre for Adverse Drug Reactions, and Consulting Clinical Toxicologist at the National Poisons Information Service (Birmingham Centre). He qualified in Chemistry from University College London, and undertook research in Paris and Oxford before returning to London to study Medicine.

Teaching

  • SCRIPT eLearning suite for safer prescribing 
  • MSc Pharmacy
  • MSc Toxicology

Research

Research concentrates on the harms and prevention of harms from medicines.

Other activities

  • Royal College of Physicians/British Pharmacological Society Joint Specialist Committee on Clinical Pharmacology and Therapeutics
  • Royal College of Physicians Patient Safety Committee
  • Joint Royal Colleges Medicines Safety Group

Publications

Highlight publications

Ferner, RE & Aronson, JK 2020, '', BMJ, pp. m1432.

Ferner, R & Aronson, JK 2006, '', Drug Safety, vol. 29, no. 11, pp. 1011-22.

McDowell, S, Coleman, J & Ferner, R 2006, '', British Medical Journal, vol. 332, no. 7551, pp. 1177-81.

Recent publications

Article

Sanghvi, S, Ferner, RE, Scourfield, A, Urquhart, R, Amin, S, Hingorani, AD & Sofat, R 2023, '', British Journal of Clinical Pharmacology.

O'callaghan, S, Ferner, R, Barron, A, Saxby, K & Sofat, R 2022, '', British Journal of Clinical Pharmacology, vol. 88, no. 6, pp. 2571-2580.

Adeyere, E, Maniero, C, Magavern, E, Ferner, R & McGettigan, P 2022, '', British Journal of Clinical Pharmacology, vol. 88, no. 11, pp. 4724-4731.

Ferner, R, Stevens, R, Anton, C & Aronson, J 2022, '', Drug Safety, vol. 45, no. 2, pp. 137-144.

Ferner, R, Mason, J, Vallance, H, Choudhary, T, Marriott, J, Coleman, J & Pontefract, S 2021, '', British Journal of Clinical Pharmacology.

Ferner, R 2021, '', The Medico-legal journal, vol. 89, no. 2, pp. 84-92.

Cox, AR & Ferner, R 2021, '', BMJ evidence-based medicine, vol. 26, no. 6, pp. E17.

Ferner, R & Pucci, M 2020, '', Medicine, vol. 48, no. 7, pp. 443-449.

Sanghvi, S, Allen, R, Cho, S, Ferner, RE, Urquhart, R & Sofat, R 2020, '', British Journal of Clinical Pharmacology.

Aronson, JK & Ferner, RE 2020, '', BMJ, pp. m1313.

Review article

Aronson, JK, Heneghan, C & Ferner, RE 2023, '', British Journal of Clinical Pharmacology.

Aronson, JK, Heneghan, C & Ferner, RE 2023, '', British Journal of Clinical Pharmacology.

Ferner, RE & Aronson, JK 2022, '', British Journal of Clinical Pharmacology.

Ferner, R, Day, R & Bradberry, S 2022, '', Expert Opinion on Drug Safety, vol. 21, no. 7, pp. 957-977.

Bennett, F, Ferner, R & Sofat, R 2021, '', British Journal of Clinical Pharmacology, vol. 87, no. 1, pp. 34-38.

Expertise

Clinical Pharmacology